Uracil plaster for hand-foot syndrome from chemotherapy
Part of Cancer, Skin clinical trials.
This trial tests a plaster containing uracil (a natural substance) to treat hand-foot syndrome, a painful skin reaction caused by chemotherapy. It may help reduce redness, swelling, and peeling on your hands and feet.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have hand-foot syndrome caused by chemotherapy, rated as mild or moderate (not severe).
- You are able to take care of yourself and have good daily function (ECOG score 0, 1, or 2).
- If you are a woman who can still have children, you agree to use birth control during the study.
- You agree to return for follow-up visits and sign a consent form.
- You do not have severe hand-foot syndrome, are not pregnant or breastfeeding, and do not have skin conditions that could affect results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a light-based therapy (photobiomodulation) can reduce pain and skin irritation from hand-foot syndrome/hand-foot skin reaction in people getting chemotherapy or targeted medicines. It may help you heal sooner and feel more comfortable while treatment continues.
This study tests an investigational gel called TAR-0520 to prevent hand-foot syndrome (pain, redness, peeling) in people starting capecitabine chemotherapy for breast or colorectal cancer. You apply the gel to your hands and feet before and during treatment to see if it helps reduce skin side effects.
This trial tests if electroacupuncture combined with self-administered acupressure can prevent hand-foot syndrome, a common side effect of the chemotherapy drug capecitabine. It is for people with gastrointestinal or breast cancer who are starting capecitabine for the first time.
This trial tests whether a special cream containing N-acetylcysteine and urea can prevent the painful hand-foot syndrome often caused by the chemotherapy drug capecitabine. If you have breast cancer and are about to start capecitabine, this study may help reduce side effects.
This study tests whether a topical anti-inflammatory cream (indomethacin) applied preventively to hands and feet can reduce a painful skin side effect called hand-foot syndrome that occurs in advanced liver cancer patients taking sorafenib. If effective, it could help patients tolerate their cancer medication better.
This trial tests whether a corticosteroid cream can prevent or reduce hand-foot skin reactions caused by liposomal doxorubicin (a type of chemotherapy) in breast cancer patients. If you are starting this chemo and are concerned about skin side effects, this study may offer a way to manage them.
Hear when a new HFS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.